European pharma shares drop after Trump threatens more tariffs

Core Viewpoint - Shares in Europe's largest pharmaceutical companies experienced a decline in early trading due to the announcement of new tariffs by U.S. President Donald Trump, which includes a 100% duty on branded drugs [1] Group 1 - The announcement of tariffs has led to a negative market reaction for European pharmaceutical companies [1] - The specific impact of the 100% duties on branded drugs raises concerns about profitability and market access for these companies [1]